Global Premature Ejaculation Treatment Market Research Report 2021

Publisher Name :
Date: 13-Oct-2021
No. of pages: 117
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Antidepressants (SSRIs)

- Type 5 Phosphodiesterase Inhibitor

- Local Anesthetics

- Traditional Chinese Medicine

- Ethnic Medicine

Segment by Application

- Human Medicine

- Veterinary Drugs

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Pfizer

- Bayer

- Menarini

- Lilly

- Johnson & Johnson

- GlaxoSmithKline

- Hotan Uighur Pharmaceutical

- Sichuan Kelun Pharmaceutical

- Guangdong T&K Pharmaceutical Factory

- Beijing Tongrentang

- Tai Chi Group

- Guangzhou Baiyunshan Pharmaceutical

- Jiangxi Huiren Pharmaceutical

- Jiuzhitang

Global Premature Ejaculation Treatment Market Research Report 2021

Table of Contents
1 Premature Ejaculation Treatment Market Overview
1.1 Product Overview and Scope of Premature Ejaculation Treatment
1.2 Premature Ejaculation Treatment Segment by Type
1.2.1 Global Premature Ejaculation Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Antidepressants (SSRIs)
1.2.3 Type 5 Phosphodiesterase Inhibitor
1.2.4 Local Anesthetics
1.2.5 Traditional Chinese Medicine
1.2.6 Ethnic Medicine
1.3 Premature Ejaculation Treatment Segment by Application
1.3.1 Global Premature Ejaculation Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Human Medicine
1.3.3 Veterinary Drugs
1.4 Global Premature Ejaculation Treatment Market Size Estimates and Forecasts
1.4.1 Global Premature Ejaculation Treatment Revenue 2016-2027
1.4.2 Global Premature Ejaculation Treatment Sales 2016-2027
1.4.3 Premature Ejaculation Treatment Market Size by Region: 2016 Versus 2021 Versus 2027
2 Premature Ejaculation Treatment Market Competition by Manufacturers
2.1 Global Premature Ejaculation Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global Premature Ejaculation Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Premature Ejaculation Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Premature Ejaculation Treatment Manufacturing Sites, Area Served, Product Type
2.5 Premature Ejaculation Treatment Market Competitive Situation and Trends
2.5.1 Premature Ejaculation Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Premature Ejaculation Treatment Players Market Share by Revenue
2.5.3 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Premature Ejaculation Treatment Retrospective Market Scenario by Region
3.1 Global Premature Ejaculation Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Premature Ejaculation Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Premature Ejaculation Treatment Market Facts & Figures by Country
3.3.1 North America Premature Ejaculation Treatment Sales by Country
3.3.2 North America Premature Ejaculation Treatment Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Premature Ejaculation Treatment Market Facts & Figures by Country
3.4.1 Europe Premature Ejaculation Treatment Sales by Country
3.4.2 Europe Premature Ejaculation Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Premature Ejaculation Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Premature Ejaculation Treatment Sales by Region
3.5.2 Asia Pacific Premature Ejaculation Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Premature Ejaculation Treatment Market Facts & Figures by Country
3.6.1 Latin America Premature Ejaculation Treatment Sales by Country
3.6.2 Latin America Premature Ejaculation Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Premature Ejaculation Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Premature Ejaculation Treatment Sales by Country
3.7.2 Middle East and Africa Premature Ejaculation Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Premature Ejaculation Treatment Historic Market Analysis by Type
4.1 Global Premature Ejaculation Treatment Sales Market Share by Type (2016-2021)
4.2 Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
4.3 Global Premature Ejaculation Treatment Price by Type (2016-2021)
5 Global Premature Ejaculation Treatment Historic Market Analysis by Application
5.1 Global Premature Ejaculation Treatment Sales Market Share by Application (2016-2021)
5.2 Global Premature Ejaculation Treatment Revenue Market Share by Application (2016-2021)
5.3 Global Premature Ejaculation Treatment Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Premature Ejaculation Treatment Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Premature Ejaculation Treatment Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Menarini
6.3.1 Menarini Corporation Information
6.3.2 Menarini Description and Business Overview
6.3.3 Menarini Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Menarini Premature Ejaculation Treatment Product Portfolio
6.3.5 Menarini Recent Developments/Updates
6.4 Lilly
6.4.1 Lilly Corporation Information
6.4.2 Lilly Description and Business Overview
6.4.3 Lilly Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lilly Premature Ejaculation Treatment Product Portfolio
6.4.5 Lilly Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Johnson & Johnson Premature Ejaculation Treatment Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GlaxoSmithKline Premature Ejaculation Treatment Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Hotan Uighur Pharmaceutical
6.6.1 Hotan Uighur Pharmaceutical Corporation Information
6.6.2 Hotan Uighur Pharmaceutical Description and Business Overview
6.6.3 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product Portfolio
6.7.5 Hotan Uighur Pharmaceutical Recent Developments/Updates
6.8 Sichuan Kelun Pharmaceutical
6.8.1 Sichuan Kelun Pharmaceutical Corporation Information
6.8.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.8.3 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product Portfolio
6.8.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.9 Guangdong T&K Pharmaceutical Factory
6.9.1 Guangdong T&K Pharmaceutical Factory Corporation Information
6.9.2 Guangdong T&K Pharmaceutical Factory Description and Business Overview
6.9.3 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product Portfolio
6.9.5 Guangdong T&K Pharmaceutical Factory Recent Developments/Updates
6.10 Beijing Tongrentang
6.10.1 Beijing Tongrentang Corporation Information
6.10.2 Beijing Tongrentang Description and Business Overview
6.10.3 Beijing Tongrentang Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Beijing Tongrentang Premature Ejaculation Treatment Product Portfolio
6.10.5 Beijing Tongrentang Recent Developments/Updates
6.11 Tai Chi Group
6.11.1 Tai Chi Group Corporation Information
6.11.2 Tai Chi Group Premature Ejaculation Treatment Description and Business Overview
6.11.3 Tai Chi Group Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Tai Chi Group Premature Ejaculation Treatment Product Portfolio
6.11.5 Tai Chi Group Recent Developments/Updates
6.12 Guangzhou Baiyunshan Pharmaceutical
6.12.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
6.12.2 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Description and Business Overview
6.12.3 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product Portfolio
6.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
6.13 Jiangxi Huiren Pharmaceutical
6.13.1 Jiangxi Huiren Pharmaceutical Corporation Information
6.13.2 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Description and Business Overview
6.13.3 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product Portfolio
6.13.5 Jiangxi Huiren Pharmaceutical Recent Developments/Updates
6.14 Jiuzhitang
6.14.1 Jiuzhitang Corporation Information
6.14.2 Jiuzhitang Premature Ejaculation Treatment Description and Business Overview
6.14.3 Jiuzhitang Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jiuzhitang Premature Ejaculation Treatment Product Portfolio
6.14.5 Jiuzhitang Recent Developments/Updates
7 Premature Ejaculation Treatment Manufacturing Cost Analysis
7.1 Premature Ejaculation Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Premature Ejaculation Treatment
7.4 Premature Ejaculation Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Premature Ejaculation Treatment Distributors List
8.3 Premature Ejaculation Treatment Customers
9 Premature Ejaculation Treatment Market Dynamics
9.1 Premature Ejaculation Treatment Industry Trends
9.2 Premature Ejaculation Treatment Growth Drivers
9.3 Premature Ejaculation Treatment Market Challenges
9.4 Premature Ejaculation Treatment Market Restraints
10 Global Market Forecast
10.1 Premature Ejaculation Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Premature Ejaculation Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Premature Ejaculation Treatment by Type (2022-2027)
10.2 Premature Ejaculation Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Premature Ejaculation Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Premature Ejaculation Treatment by Application (2022-2027)
10.3 Premature Ejaculation Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Premature Ejaculation Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Premature Ejaculation Treatment by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Premature Ejaculation Treatment Sales (Boxs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Premature Ejaculation Treatment Sales (Boxs) Comparison by Application (2021-2027)
Table 3. Global Premature Ejaculation Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Premature Ejaculation Treatment Covered in This Study
Table 5. Global Premature Ejaculation Treatment Sales (Boxs) of Key Manufacturers (2016-2021)
Table 6. Global Premature Ejaculation Treatment Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Premature Ejaculation Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Premature Ejaculation Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Premature Ejaculation Treatment Average Price (Yuan/Box) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Premature Ejaculation Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers Premature Ejaculation Treatment Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Premature Ejaculation Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Ejaculation Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Premature Ejaculation Treatment Sales by Region (2016-2021) & (Boxs)
Table 16. Global Premature Ejaculation Treatment Sales Market Share by Region (2016-2021)
Table 17. Global Premature Ejaculation Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Premature Ejaculation Treatment Sales by Country (2016-2021) & (Boxs)
Table 19. North America Premature Ejaculation Treatment Sales Market Share by Country (2016-2021)
Table 20. North America Premature Ejaculation Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Premature Ejaculation Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe Premature Ejaculation Treatment Sales by Country (2016-2021) & (Boxs)
Table 23. Europe Premature Ejaculation Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe Premature Ejaculation Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Premature Ejaculation Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Premature Ejaculation Treatment Sales by Region (2016-2021) & (Boxs)
Table 27. Asia Pacific Premature Ejaculation Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Premature Ejaculation Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Premature Ejaculation Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America Premature Ejaculation Treatment Sales by Country (2016-2021) & (Boxs)
Table 31. Latin America Premature Ejaculation Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America Premature Ejaculation Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Premature Ejaculation Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Premature Ejaculation Treatment Sales by Country (2016-2021) & (Boxs)
Table 35. Middle East and Africa Premature Ejaculation Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Premature Ejaculation Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Premature Ejaculation Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global Premature Ejaculation Treatment Sales (Boxs) by Type (2016-2021)
Table 39. Global Premature Ejaculation Treatment Sales Market Share by Type (2016-2021)
Table 40. Global Premature Ejaculation Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global Premature Ejaculation Treatment Revenue Share by Type (2016-2021)
Table 42. Global Premature Ejaculation Treatment Price (Yuan/Box) by Type (2016-2021)
Table 43. Global Premature Ejaculation Treatment Sales (Boxs) by Application (2016-2021)
Table 44. Global Premature Ejaculation Treatment Sales Market Share by Application (2016-2021)
Table 45. Global Premature Ejaculation Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global Premature Ejaculation Treatment Revenue Share by Application (2016-2021)
Table 47. Global Premature Ejaculation Treatment Price (Yuan/Box) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 51. Pfizer Premature Ejaculation Treatment Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 56. Bayer Premature Ejaculation Treatment Product
Table 57. Bayer Recent Developments/Updates
Table 58. Menarini Corporation Information
Table 59. Menarini Description and Business Overview
Table 60. Menarini Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 61. Menarini Premature Ejaculation Treatment Product
Table 62. Menarini Recent Developments/Updates
Table 63. Lilly Corporation Information
Table 64. Lilly Description and Business Overview
Table 65. Lilly Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 66. Lilly Premature Ejaculation Treatment Product
Table 67. Lilly Recent Developments/Updates
Table 68. Johnson & Johnson Corporation Information
Table 69. Johnson & Johnson Description and Business Overview
Table 70. Johnson & Johnson Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 71. Johnson & Johnson Premature Ejaculation Treatment Product
Table 72. Johnson & Johnson Recent Developments/Updates
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Business Overview
Table 75. GlaxoSmithKline Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 76. GlaxoSmithKline Premature Ejaculation Treatment Product
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. Hotan Uighur Pharmaceutical Corporation Information
Table 79. Hotan Uighur Pharmaceutical Description and Business Overview
Table 80. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 81. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product
Table 82. Hotan Uighur Pharmaceutical Recent Developments/Updates
Table 83. Sichuan Kelun Pharmaceutical Corporation Information
Table 84. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 85. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 86. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product
Table 87. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 88. Guangdong T&K Pharmaceutical Factory Corporation Information
Table 89. Guangdong T&K Pharmaceutical Factory Description and Business Overview
Table 90. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 91. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product
Table 92. Guangdong T&K Pharmaceutical Factory Recent Developments/Updates
Table 93. Beijing Tongrentang Corporation Information
Table 94. Beijing Tongrentang Description and Business Overview
Table 95. Beijing Tongrentang Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 96. Beijing Tongrentang Premature Ejaculation Treatment Product
Table 97. Beijing Tongrentang Recent Developments/Updates
Table 98. Tai Chi Group Corporation Information
Table 99. Tai Chi Group Description and Business Overview
Table 100. Tai Chi Group Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 101. Tai Chi Group Premature Ejaculation Treatment Product
Table 102. Tai Chi Group Recent Developments/Updates
Table 103. Guangzhou Baiyunshan Pharmaceutical Corporation Information
Table 104. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 105. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 106. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product
Table 107. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 108. Jiangxi Huiren Pharmaceutical Corporation Information
Table 109. Jiangxi Huiren Pharmaceutical Description and Business Overview
Table 110. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 111. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product
Table 112. Jiangxi Huiren Pharmaceutical Recent Developments/Updates
Table 113. Jiuzhitang Corporation Information
Table 114. Jiuzhitang Description and Business Overview
Table 115. Jiuzhitang Premature Ejaculation Treatment Sales (Boxs), Revenue (Million US$), Price (Yuan/Box) and Gross Margin (2016-2021)
Table 116. Jiuzhitang Premature Ejaculation Treatment Product
Table 117. Jiuzhitang Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Premature Ejaculation Treatment Distributors List
Table 121. Premature Ejaculation Treatment Customers List
Table 122. Premature Ejaculation Treatment Market Trends
Table 123. Premature Ejaculation Treatment Growth Drivers
Table 124. Premature Ejaculation Treatment Market Challenges
Table 125. Premature Ejaculation Treatment Market Restraints
Table 126. Global Premature Ejaculation Treatment Sales Forecast by Type (2022-2027) & (Boxs)
Table 127. Global Premature Ejaculation Treatment Sales Market Share Forecast by Type (2022-2027)
Table 128. Global Premature Ejaculation Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 129. Global Premature Ejaculation Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 130. Global Premature Ejaculation Treatment Sales Forecast by Application (2022-2027) & (Boxs)
Table 131. Global Premature Ejaculation Treatment Sales Market Share Forecast by Application (2022-2027)
Table 132. Global Premature Ejaculation Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 133. Global Premature Ejaculation Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 134. Global Premature Ejaculation Treatment Sales Forecast by Region (2022-2027) & (Boxs)
Table 135. Global Premature Ejaculation Treatment Sales Market Share Forecast by Region (2022-2027)
Table 136. Global Premature Ejaculation Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 137. Global Premature Ejaculation Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Premature Ejaculation Treatment
Figure 2. Global Premature Ejaculation Treatment Market Share by Type in 2020 & 2027
Figure 3. Antidepressants (SSRIs) Product Picture
Figure 4. Type 5 Phosphodiesterase Inhibitor Product Picture
Figure 5. Local Anesthetics Product Picture
Figure 6. Traditional Chinese Medicine Product Picture
Figure 7. Ethnic Medicine Product Picture
Figure 8. Global Premature Ejaculation Treatment Market Share by Application in 2020 & 2027
Figure 9. Human Medicine
Figure 10. Veterinary Drugs
Figure 11. Global Premature Ejaculation Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Premature Ejaculation Treatment Market Size 2016-2027 (US$ Million)
Figure 13. Global Premature Ejaculation Treatment Sales 2016-2027 (Boxs)
Figure 14. Global Premature Ejaculation Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Premature Ejaculation Treatment Sales Share by Manufacturers in 2020
Figure 16. Global Premature Ejaculation Treatment Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Premature Ejaculation Treatment Players: Market Share by Revenue in 2020
Figure 18. Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Premature Ejaculation Treatment Sales Market Share by Region (2016-2021)
Figure 20. Global Premature Ejaculation Treatment Sales Market Share by Region in 2020
Figure 21. Global Premature Ejaculation Treatment Revenue Market Share by Region (2016-2021)
Figure 22. Global Premature Ejaculation Treatment Revenue Market Share by Region in 2020
Figure 23. United States Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Premature Ejaculation Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Premature Ejaculation Treatment by Type (2016-2021)
Figure 46. Sales Market Share of Premature Ejaculation Treatment by Application (2016-2021)
Figure 47. Sales Market Share of Premature Ejaculation Treatment by Application in 2020
Figure 48. Revenue Share of Premature Ejaculation Treatment by Application (2016-2021)
Figure 49. Revenue Share of Premature Ejaculation Treatment by Application in 2020
Figure 50. Manufacturing Cost Structure of Premature Ejaculation Treatment
Figure 51. Manufacturing Process Analysis of Premature Ejaculation Treatment
Figure 52. Premature Ejaculation Treatment Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
  • Global Testosterone Replacement Therapy Market Insights and Forecast to 2028
    Published: 25-Jan-2022        Price: US 4900 Onwards        Pages: 107
    Testosterone Replacement Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Testosterone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Gels - Injections - Patches - Other Segment b......
  • Global Premature Ejaculation Treatment Market Insights and Forecast to 2028
    Published: 12-Jan-2022        Price: US 4900 Onwards        Pages: 106
    Premature Ejaculation Treatment market is segmented by players, region (country), by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Premature Ejaculation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel for the period 2017-2028. Segment by Type - Antidepressants(SSRIs) - Phosphodiest......
  • Global Premature Ejaculation Treatment Market Outlook 2022
    Published: 10-Jan-2022        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Antidepressants (SSRIs) - Type 5 Phosphodiesterase Inhibitor - Local Anesthetics - Traditional Chine......
  • Global Erectile Dysfunction Drugs Market Outlook 2022
    Published: 07-Jan-2022        Price: US 2900 Onwards        Pages: 110
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Sildenafil - Tadalafil - Others Segment by Application - Hospital Pharmacies -......
  • Global Male Infertility Market, 2021-2027
    Published: 07-Jan-2022        Price: US 2400 Onwards        Pages: 68
    Male infertility is any health issue in a man that lowers the chances of his female partner getting pregnant. Infertility can be caused by low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Gen Consulting Company predicts global male infertility market will grow from USD 2,355 million in 2020 to USD 3,292 million by 2027, achieving a CAGR of 4.9 percent, according to the latest edition of the Global Male Infertility Market Report. The repo......
  • Global Testosterone Replacement Therapy Market Outlook 2022
    Published: 05-Jan-2022        Price: US 2900 Onwards        Pages: 112
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Gels - Injections - Patches - Other Segment by Application - Hospitals ......
  • China Duchenne Muscular Dystrophy Drugs Market Report & Forecast 2021-2027
    Published: 27-Dec-2021        Price: US 3400 Onwards        Pages: 93
    China Duchenne Muscular Dystrophy Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Duchenne Muscular Dystrophy Drugs Market Segment Percentages, By Type, 2020 (%) - Molecular-based Therapies - Steroid Therapy - Other China Duchenne Muscular Dystrophy Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Duchenne Muscular Dystrophy Drugs Market Segment Percentages, By Application, 2020 (%) - Hospitals - ......
  • United States Methyltestosterone Market Report & Forecast 2021-2027
    Published: 08-Dec-2021        Price: US 3400 Onwards        Pages: 92
    United States Methyltestosterone Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Methyltestosterone Market Segment Percentages, By Type, 2020 (%) - Capsules - Tablets United States Methyltestosterone Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Methyltestosterone Market Segment Percentages, By Application, 2020 (%) - Low Testosterone Levels in Men - Delayed Puberty in Boys......
  • United States Finasteride Tablets Market Report & Forecast 2021-2027
    Published: 02-Dec-2021        Price: US 3400 Onwards        Pages: 91
    United States Finasteride Tablets Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Finasteride Tablets Market Segment Percentages, By Type, 2020 (%) - 1mg Tablet - 5mg Tablet United States Finasteride Tablets Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Finasteride Tablets Market Segment Percentages, By Application, 2020 (%) - Benign Prostatic Hyperplasia - Male Pattern Bal......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs